Bajaj Healthcare per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹6.06₹4.98₹13.29−₹30.36₹15.59
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹5.96₹4.97₹13.12−₹30.36₹15.59
₹158.34₹158.34₹147.60₹100.86₹133.23
₹194.82₹181.52₹171.80₹171.54₹243.96
—₹17.25₹6.85₹33.44−₹8.09
₹4.38₹4.38₹3.19₹22.47−₹42.00
—₹0.94₹0.87₹1.00₹1.50
3.43.43.22.82.8
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BAJAJHCARE₹314.45

Bajaj Healthcare Limited

· Pharma & Health
₹ CrorePeersTHEMISMEDLINCOLNWANBURYSIGACHIAHCLANUHPHRAMRUTANJANMcap ₹1,059 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS15.59-30.3613.294.986.06
Diluted EPS15.59-30.3613.124.975.96
Book Value per Share133.23100.86147.60158.34158.34
Revenue per Share243.96171.54171.80181.52194.82
Cash Flow per Share-8.0933.446.8517.25—
Free Cash Flow per Share-42.0022.473.194.384.38
Dividends per Share1.501.000.870.94—
Shares Outstanding (cr)2.82.83.23.43.4
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.